2024 Q2 Form 10-Q Financial Statement
#000168316824003431 Filed on May 15, 2024
Income Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
Revenue | $4.591M | $4.171M |
YoY Change | 2.18% | -6.98% |
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $4.150M | $4.054M |
YoY Change | -3.26% | -3.57% |
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | $44.00K | $44.00K |
YoY Change | -26.67% | -13.73% |
% of Gross Profit | ||
Operating Expenses | $4.194M | $4.098M |
YoY Change | -3.45% | -3.69% |
Operating Profit | $397.0K | $73.00K |
YoY Change | 166.44% | -68.12% |
Interest Expense | $77.00K | $3.000K |
YoY Change | 200.0% | |
% of Operating Profit | 19.4% | 4.11% |
Other Income/Expense, Net | $77.00K | $76.00K |
YoY Change | -226.23% | -500.0% |
Pretax Income | $474.0K | $149.0K |
YoY Change | 438.64% | -29.05% |
Income Tax | $227.0K | $58.00K |
% Of Pretax Income | 47.89% | 38.93% |
Net Earnings | $247.0K | $91.00K |
YoY Change | -1864.29% | -42.77% |
Net Earnings / Revenue | 5.38% | 2.18% |
Basic Earnings Per Share | $0.05 | $0.02 |
Diluted Earnings Per Share | $0.05 | $0.02 |
COMMON SHARES | ||
Basic Shares Outstanding | 5.157M shares | 5.157M |
Diluted Shares Outstanding | 5.157K shares | 5.157K shares |
Balance Sheet
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $11.99M | $11.40M |
YoY Change | 9.99% | 5.0% |
Cash & Equivalents | $5.712M | $4.734M |
Short-Term Investments | $6.277M | $6.670M |
Other Short-Term Assets | $105.0K | $228.0K |
YoY Change | -47.5% | -24.0% |
Inventory | ||
Prepaid Expenses | ||
Receivables | $9.210M | $8.585M |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $21.30M | $20.22M |
YoY Change | 0.86% | -3.15% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $268.0K | $291.0K |
YoY Change | -21.18% | -15.41% |
Goodwill | $7.547M | $7.547M |
YoY Change | 0.0% | 0.0% |
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $299.0K | $301.0K |
YoY Change | -0.66% | -2.27% |
Total Long-Term Assets | $19.83M | $20.03M |
YoY Change | -1.82% | -1.71% |
TOTAL ASSETS | ||
Total Short-Term Assets | $21.30M | $20.22M |
Total Long-Term Assets | $19.83M | $20.03M |
Total Assets | $41.13M | $40.25M |
YoY Change | -0.45% | -2.44% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $4.045M | $3.722M |
YoY Change | 3.72% | -8.55% |
Accrued Expenses | $741.0K | $727.0K |
YoY Change | 23.5% | 54.35% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | $33.00K | $33.00K |
YoY Change | -67.0% | -47.62% |
Total Short-Term Liabilities | $11.63M | $11.01M |
YoY Change | -5.72% | -11.09% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $105.0K | $114.0K |
YoY Change | 5.0% | 67.65% |
Other Long-Term Liabilities | $2.692M | $2.898M |
YoY Change | -15.88% | -13.39% |
Total Long-Term Liabilities | $4.281M | $4.273M |
YoY Change | -2.19% | -2.75% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $11.63M | $11.01M |
Total Long-Term Liabilities | $4.281M | $4.273M |
Total Liabilities | $15.91M | $15.28M |
YoY Change | -4.79% | -8.91% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$56.94M | -$57.19M |
YoY Change | -1.09% | -0.63% |
Common Stock | $88.93M | $88.93M |
YoY Change | 0.05% | 0.08% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $25.22M | $24.97M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $41.13M | $40.25M |
YoY Change | -0.45% | -2.44% |
Cashflow Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $247.0K | $91.00K |
YoY Change | -1864.29% | -42.77% |
Depreciation, Depletion And Amortization | $44.00K | $44.00K |
YoY Change | -26.67% | -13.73% |
Cash From Operating Activities | $493.0K | -$1.316M |
YoY Change | 1543.33% | 15.95% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $11.00K | $6.000K |
YoY Change | -72.5% | -91.78% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $476.0K | $1.000K |
YoY Change | ||
Cash From Investing Activities | $465.0K | -$5.000K |
YoY Change | -1262.5% | -93.15% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 16.00K | -$32.00K |
YoY Change | -260.0% | 113.33% |
NET CHANGE | ||
Cash From Operating Activities | 493.0K | -$1.316M |
Cash From Investing Activities | 465.0K | -$5.000K |
Cash From Financing Activities | 16.00K | -$32.00K |
Net Change In Cash | 974.0K | -$1.383M |
YoY Change | -4970.0% | 21.64% |
FREE CASH FLOW | ||
Cash From Operating Activities | $493.0K | -$1.316M |
Capital Expenditures | $11.00K | $6.000K |
Free Cash Flow | $482.0K | -$1.322M |
YoY Change | -4920.0% | 9.44% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-57276000 | usd |
CY2024Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-406000 | usd |
CY2023Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-376000 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
24968000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
24896000 | usd |
CY2024Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
40251000 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
41665000 | usd |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2024Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
9000000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
9000000000 | shares |
CY2024Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
6472038000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
6472038000 | shares |
CY2024Q1 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
1314694000 | shares |
CY2023Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
1314694000 | shares |
CY2024Q1 | us-gaap |
Treasury Stock Common Value
TreasuryStockCommonValue
|
6371000 | usd |
CY2023Q4 | us-gaap |
Treasury Stock Common Value
TreasuryStockCommonValue
|
6371000 | usd |
CY2024Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
88865000 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
88854000 | usd |
CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-57185000 | usd |
CY2024Q1 | WHLM |
Service Revenues
ServiceRevenues
|
4163000 | usd |
CY2023Q1 | WHLM |
Service Revenues
ServiceRevenues
|
4476000 | usd |
CY2024Q1 | WHLM |
License Fees And Other Income
LicenseFeesAndOtherIncome
|
8000 | usd |
CY2023Q1 | WHLM |
License Fees And Other Income
LicenseFeesAndOtherIncome
|
8000 | usd |
CY2024Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
2966000 | usd |
CY2023Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
2880000 | usd |
CY2024Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
835000 | usd |
CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1080000 | usd |
CY2024Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
44000 | usd |
CY2023Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
51000 | usd |
CY2024Q1 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
253000 | usd |
CY2023Q1 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
244000 | usd |
CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
4098000 | usd |
CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
4255000 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
73000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
229000 | usd |
CY2024Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-7000 | usd |
CY2023Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-18000 | usd |
CY2024Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
86000 | usd |
CY2023Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
-0 | usd |
CY2024Q1 | us-gaap |
Interest Expense
InterestExpense
|
3000 | usd |
CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
1000 | usd |
CY2024Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
76000 | usd |
CY2023Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-19000 | usd |
CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
149000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
210000 | usd |
CY2024Q1 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
12000 | usd |
CY2023Q1 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
56000 | usd |
CY2024Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
46000 | usd |
CY2023Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-5000 | usd |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
58000 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
51000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
91000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
159000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-30000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
86000 | usd |
CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
61000 | usd |
CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
245000 | usd |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.02 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.03 | |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.02 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.03 | |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5157 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
5157 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5157 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
5157 | shares |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
24211000 | usd |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
24000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
159000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
86000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
24480000 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
24896000 | usd |
CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
11000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
91000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-30000 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
24968000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
91000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
159000 | usd |
CY2024Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
44000 | usd |
CY2023Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
51000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
11000 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
24000 | usd |
CY2024Q1 | us-gaap |
Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
|
7000 | usd |
CY2023Q1 | us-gaap |
Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
|
15000 | usd |
CY2024Q1 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
46000 | usd |
CY2023Q1 | us-gaap |
Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
|
-5000 | usd |
CY2024Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
29000 | usd |
CY2023Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
45000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
191000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
312000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
25000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
117000 | usd |
CY2024Q1 | WHLM |
Increase Decrease In Operating Right Of Use Assets
IncreaseDecreaseInOperatingRightOfUseAssets
|
-172000 | usd |
CY2023Q1 | WHLM |
Increase Decrease In Operating Right Of Use Assets
IncreaseDecreaseInOperatingRightOfUseAssets
|
-205000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-0 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-15000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
-1116000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
-621000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-190000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-91000 | usd |
CY2024Q1 | WHLM |
Increase Decrease In Finance Lease Liability
IncreaseDecreaseInFinanceLeaseLiability
|
25000 | usd |
CY2023Q1 | WHLM |
Increase Decrease In Finance Lease Liability
IncreaseDecreaseInFinanceLeaseLiability
|
0 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
0 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-270000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-219000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-233000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1316000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1135000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
6000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
73000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
6149000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
-0 | usd |
CY2024Q1 | us-gaap |
Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
|
6150000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
|
0 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-5000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-73000 | usd |
CY2024Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
32000 | usd |
CY2023Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
15000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-32000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-15000 | usd |
CY2024Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-30000 | usd |
CY2023Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
86000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-1383000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-1137000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
6117000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
11998000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
4734000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
10861000 | usd |
CY2024Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
7000 | usd |
CY2023Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
0 | usd |
CY2024Q1 | us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<p id="xdx_805_eus-gaap--BasisOfAccounting_zMBwbwveq4Pg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Note 1. <span id="xdx_825_zgYrjisIRd7h">Basis of Presentation</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The interim consolidated financial statements included herein have been prepared by Wilhelmina International, Inc. (together with its subsidiaries, “Wilhelmina” or the “Company”) without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Although certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to those rules and regulations, all adjustments considered necessary in order to make the consolidated financial statements not misleading have been included. In the opinion of the Company’s management, the accompanying interim unaudited consolidated financial statements reflect all adjustments, of a normal recurring nature, that are necessary for a fair presentation of the Company’s consolidated balance sheets, statements of operations and comprehensive income, statements of shareholders’ equity, and cash flows for the periods presented. These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023. Results of operations for the interim periods are not necessarily indicative of results that may be expected for any other interim periods or the full fiscal year.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> | |
CY2024Q1 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
0 | usd |
CY2012Q4 | srt |
Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
|
500000 | shares |
CY2013Q4 | srt |
Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
|
1000000 | shares |
CY2016 | WHLM |
Stock Repurchase Program Additional Shares Authorized
StockRepurchaseProgramAdditionalSharesAuthorized
|
500000 | shares |
CY2016Q4 | srt |
Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
|
1500000 | shares |
us-gaap |
Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
|
1314694 | shares | |
us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
4.85 | ||
us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
6400000 | usd | |
CY2024Q1 | us-gaap |
Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
|
0 | usd |
CY2024Q1 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
11404 | usd |
CY2023Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
12713 | usd |
CY2024Q1 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false |